A King’s College London clinical trial involving the cannabis compound CBD has shown it may be beneficial in treating psychosis in schizophrenia. While cannabis can pose a risk to people with schizophrenia, this is thought to be primarily due to the effects tetrahydrocannabinol (THC), a psychoactive component that can induce...
It seems medical cannabis products containing higher levels of THC will soon be available in Mexico. According to a report published on Riviera Maya News, the federal commissioner of COFEPRIS (Federal Committee for Protection from Sanitary Risks) has indicated cannabis-based medicine will be available in Mexico reasonably early next year. Currently, cannabis...
Hawaii's Department of Health last week announced it had added Amyotrophic Lateral Sclerosis (ALS) to its list of qualifying conditions for medical cannabis use. ALS is also often referred to as motor neurone disease (MND) or Lou Gehrig's disease. It's a condition that impacts on the nervous system, weakening muscles....
PUF Ventures Australia (PUFA) announced last week it was changing its name to Solaris Nutraceuticals Pty. Ltd. “The new name reflects our focus on distinct innovations to provide medicinal cannabis grown under the Northern Rivers sun in our proposed 1.2 million square foot Ultra-Clima glass house,” said President and CEO Michael...
Australia's Therapeutic Goods Administration has published a new series of clinical guides (not to be confused with clinical guidelines) to provide advice and explanations regarding medical cannabis. The guides were authored by a team from the Universities of New South Wales, Sydney and Queensland, who reviewed clinical evidence for the...
Queensland Bauxite Limited (ASX:QBL) subsidiary Medical Cannabis Limited is teaming up with Australia's Algae.Tec Ltd (ASX:AEB) in a project researching cannabis-based veterinary medications. AEB will exclusively license Medical Cannabis Limited’s low-THC cannabis cultivars with view to establishing a breeding program to identify strains suitable for use in developing medications for...
Medical cannabis related legislation tabled in New Zealand's Parliament on Wednesday may not be ideal, but it's a start. Health Minister Dr David Clark introduced the Misuse of Drugs Amendment Bill, which seeks to implement a scheme to enable access to cannabis medicines via prescription and remove cannabidiol (CBD) from...
A new directive from the USA's Department of Veteran Affairs states VA doctors can now discuss marijuana with their patients. Up until now, doctors have been banned from discussing cannabis - a ridiculous situation given a recent survey indicated 22% of veterans were using it to treat a physical or...
The psychoactive cannabinoid THC has shown promise in slowing mental decline that can affect up to half of HIV patients. It's thought that cognitive function decrease in many HIV patients is a result of chronic inflammation that can occur in the brain, which happens due to patients' immune systems constantly...
Perth-based Little Green Pharma has announced it has commenced cultivation of Western Australia's first medical cannabis crop. The plants are being grown at the privately-owned company's secure growing facility south of Perth. Little Green Pharma expects to have medicines available for patients within the first few months of next year,...